Business

Announcement on the Voluntary Disclosure Regarding the Execution of an Exclusive Commercialization Rights Agreement by a Wholly-owned Subsidiary

Announcement on the Voluntary Disclosure Regarding the Execution of an Exclusive Commercialization Rights Agreement by a Wholly-owned Subsidiary

articleHubei Jumpcan Pharmaceutical Co., Ltd Class AFebruary 26, 20265/news/announcement-on-the-voluntary-disclosure-regarding-the-execution-of-an-exclusive-commercialization-rights-agreement-by-a-wholly-owned-subsidiary
Announcement on the Voluntary Disclosure Regarding the Execution of an Exclusive Commercialization Rights Agreement by a Wholly-owned Subsidiary

About this update from Hubei Jumpcan Pharmaceutical Co., Ltd Class A

Announcement on the Voluntary Disclosure Regarding the Execution of an Exclusive Commercialization Rights Agreement by a Wholly-owned Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hubei Jumpcan Pharmaceutical Co., Ltd Class A